Xiaohong Zhu
Overview
Explore the profile of Xiaohong Zhu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
174
Citations
2021
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu K, Zhang Y, Wang M, Zhu X, Maboudian R, Tsang D
Adv Sci (Weinh)
. 2025 Feb;
:e2417737.
PMID: 40019354
Impurities are pivotal in determining the quality of the critical metal products derived from spent lithium-ion batteries (LIBs), but there is a lack of understanding of their potential impacts. The...
2.
Zhu X, Cao L, Wang J, Lu X, Huang Z, Wen X, et al.
Infect Drug Resist
. 2025 Feb;
18:929-940.
PMID: 39990777
Background: The rapid and accurate identification of infectious pathogens in HIV-infected patients remains a challenge. Metagenomic next-generation sequencing (mNGS) is a panpathogen assay for rapid diagnosis of infectious diseases. Here,...
3.
Wang B, Xie R, Qi W, Yao J, Shi Y, Lou X, et al.
BMJ Open
. 2025 Feb;
15(2):e092293.
PMID: 39922598
Objectives: Alzheimer's disease (AD) poses a significant challenge for individuals aged 65 and older, being the most prevalent form of dementia. Although existing AD risk prediction tools demonstrate high accuracy,...
4.
Zhao Y, Wang X, Lei Q, Zhang X, Wang Y, Ji H, et al.
New Phytol
. 2025 Feb;
246(1):158-175.
PMID: 39909830
Mitochondria support plant growth and adaptation via energy production and signaling pathways. However, how mitochondria control the transition between growth and stress response is largely unknown in plants. Using molecular...
5.
Liu Y, Li X, Zhang M, Men Y, Wang Y, Zhu X, et al.
Drug Des Devel Ther
. 2025 Jan;
19:515-524.
PMID: 39876990
Purpose: HA121-28, a novel multi-targeting tyrosine kinase inhibitor, has dual efficacy against tumor growth and neovascularization. The objectives of this study were to assess the effect of high-fat and high-calorie...
6.
Liu C, Zhu X, Shi W, Duan Q, Yuan M, Zheng Y, et al.
Bioorg Med Chem
. 2025 Jan;
119:118066.
PMID: 39798240
Infectious diseases caused by drug-resistant bacteria represent one of the most significant global public challenges of this century. There is an urgent need for the treatment of drug-resistant Gram-negative bacterial...
7.
Shen W, Wang Q, Shen G, Gu M, Shen Q, Zhang A, et al.
Placenta
. 2025 Jan;
160:89-99.
PMID: 39787954
Introduction: Pre-eclampsia (PE) is a pregnancy complication featuring hypertension and proteinuria. Metformin exerts clinically preventive effects on PE with an unspecified mechanism. Methods: Placental tissues from PE patients and normal...
8.
Liu H, Zhu X, Ge B, Huang M, Li X
Rev Environ Health
. 2024 Dec;
PMID: 39733343
Introduction: The goal is to provide light on the contentious relationship between screen exposure and childhood autism spectrum disorder (ASD). By conducting two meta-analyses that showed a potential association, including...
9.
10.
Ma F, Ren M, Li Z, Tang Y, Sun X, Wang Y, et al.
Pharmacol Res
. 2024 Nov;
210:107499.
PMID: 39549895
ARID1A deletion mutation contributes to improved treatment of several malignancies with immune checkpoint inhibitors (ICIs). However, its role in modulating of tumor immune microenvironment (TIME) of gastric cancer (GC) remains...